Literature DB >> 1768575

Gentamicin interval in newborn infants as determined by renal function and postconceptional age.

L P Brion1, A R Fleischman, G J Schwartz.   

Abstract

We evaluated the relationship between gentamicin pharmacokinetics and glomerular filtration rate in newborn infants to estimate the appropriate interval of administration in neonates with renal insufficiency. Gentamicin half-life (Gt1/2) could be predicted from plasma creatinine concentration (PCr) (r = 0.78); the prediction was minimally but significantly increased (r = 0.81) by adding post-conceptional age to a multiple regression analysis. Infants with a postconceptional age of 29 weeks or more and a PCr of 1 mg/dl or more had significantly greater through and peak gentamicin levels than those with a PCr less than 1 mg/dl. If gentamicin is indicated in a patient with renal insufficiency, the interval of administration should be 2-3 Gt1/2, which can be estimated from PCr (Gt1/2 = 2.0 + 7.7 PCr). The interval can then be adjusted according to peak and trough gentamicin levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768575     DOI: 10.1007/bf00857868

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

1.  Mild ischemia predisposes the S3 segment to gentamicin toxicity.

Authors:  D M Spiegel; P F Shanley; B A Molitoris
Journal:  Kidney Int       Date:  1990-09       Impact factor: 10.612

2.  Gentamicin increases renal susceptibility to an acute ischemic insult.

Authors:  R A Zager; H M Sharma
Journal:  J Lab Clin Med       Date:  1983-05

Review 3.  Use of aminoglycosides in the neonate.

Authors:  L Riff; V Schauf
Journal:  Semin Perinatol       Date:  1982-04       Impact factor: 3.300

4.  Rapid, reproducible enzyme immunoassay for gentamicin.

Authors:  D Phaneuf; E Francke; H C Neu
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

5.  Reliability of plasma creatinine measurement in infants and children.

Authors:  M J Clermont; L P Brion; G J Schwartz
Journal:  Clin Pediatr (Phila)       Date:  1986-11       Impact factor: 1.168

6.  A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth.

Authors:  L P Brion; A R Fleischman; C McCarton; G J Schwartz
Journal:  J Pediatr       Date:  1986-10       Impact factor: 4.406

7.  A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn.

Authors:  G Koren; A James; M Perlman
Journal:  Clin Pharmacol Ther       Date:  1985-12       Impact factor: 6.875

8.  A simple estimate of glomerular filtration rate in full-term infants during the first year of life.

Authors:  G J Schwartz; L G Feld; D J Langford
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

9.  Limitations on the physiologic interpretation of aminoglycoside body clearance derived from pharmacokinetic studies.

Authors:  J E Riviere
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-10

10.  Determining gentamicin dosage in infants and children with renal failure.

Authors:  S Sirinavin; G H McCracken; J D Nelson
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

View more
  11 in total

1.  The effect of sepsis upon gentamicin pharmacokinetics in neonates.

Authors:  M Lingvall; D Reith; R Broadbent
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

2.  Single or multiple daily doses of aminoglycosides. More details needed of treatment in neonates and young children.

Authors:  H Campbell
Journal:  BMJ       Date:  1996-08-24

3.  Acute effects of gentamicin on glomerular and tubular functions in preterm neonates.

Authors:  Sevinç Tugay; Zelal Bircan; Ciğdem Cağlayan; Ayşe Engin Arisoy; Ayşe Sevim Gökalp
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

Review 4.  Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.

Authors:  Imke H Bartelink; Carin M A Rademaker; Alfred F A M Schobben; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Serum calcium values in term and late-preterm neonates receiving gentamicin.

Authors:  Arpitha Chiruvolu; William D Engle; Dorothy Sendelbach; M Denise Manning; Gregory L Jackson
Journal:  Pediatr Nephrol       Date:  2008-01-25       Impact factor: 3.714

Review 6.  Clinical pharmacokinetics of aminoglycosides in the neonate: a review.

Authors:  Gian Maria Pacifici
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

Review 7.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

8.  Acute effects of gentamicin on urinary electrolyte excretion in neonates.

Authors:  Vasilios I Giapros; Vasilios I Cholevas; Styliani K Andronikou
Journal:  Pediatr Nephrol       Date:  2003-12-20       Impact factor: 3.714

9.  Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study.

Authors:  Amadou Samb; Matthijs Kruizinga; Younes Tallahi; Michiel van Esdonk; Willemijn van Heel; Gertjan Driessen; Yuma Bijleveld; Rik Stuurman; Adam Cohen; Anton van Kaam; Timo R de Haan; Ron Mathôt
Journal:  Br J Clin Pharmacol       Date:  2021-11-07       Impact factor: 3.716

Review 10.  Clinical Pharmacokinetics of Penicillins, Cephalosporins and Aminoglycosides in the Neonate: A Review.

Authors:  Gian Maria Pacifici
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.